Clinical Research
The Europe, Middle-East and Africa (EMEA) region has observed a marked increase in clinical trial activities in recent years, owing to the high prevalence of various medical conditions in the area. The need for research has necessitated the provision of support and training to enable the conduct of clinical studies in these countries. Moreover, the costs associated with clinical trials in the EMEA region are comparatively lower than in the United States and Europe.
Most EMEA countries have established regulatory bodies that oversee clinical trials, with Ethics Committees (ECs) and Regulatory Authorities (RAs) adhering to International Council for Harmonisation – Good Clinical Practice (ICH-GCP) guidelines and local regulations.
Clinical trials approval in EMEA countries can be intricate and time-consuming, necessitating our specialized knowledge to expedite the approval process. Our advice and expertise can help minimize delays during start-up activities, enhancing the efficiency of the process.
We provide customized design assistance for clinical trials to comply with the various governing bodies’ requirements, in addition to support in preparing study protocols and reports for all types of formulations.
Our comprehensive clinical development services that span the entire spectrum of clinical research, from early-stage trials to post-approval programs. Our primary goal is to assist our clients in navigating the complexities of the clinical development process, resulting in a robust and innovative strategy that maximizes asset value and the likelihood of success.